Walter H. Moos

Chief Executive Officer at ShangPharma Innovation, Inc.

Walter H. Moos

Walter H. Moos

Chief Executive Officer at ShangPharma Innovation, Inc.

Overview
Career Highlights

ShangPharma Innovation, Inc.
MitoKor, Inc.

RelSci Relationships

3613

Number of Boards

14

Birthday

1955

Age

66

Relationships
RelSci Relationships are individuals Walter H. Moos likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Relay Therapeutics, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at Rigel Pharmaceuticals, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Circle Pharma, Inc.

Relationship likelihood: Strong

Former President & Chief Executive Officer at Onyx Pharmaceuticals, Inc.

Relationship likelihood: Strong

Executive-in-Residence at ShangPharma Innovation, Inc.

Relationship likelihood: Strong

President & Chief Technology Officer at Amunix Pharmaceuticals, Inc.

Relationship likelihood: Strong

Member, Adjunct Faculty at The Trudeau Institute

Relationship likelihood: Strong

Director & Chief Scientific Officer at Keystone Symposia

Relationship likelihood: Strong

Co-Founder at Red Abbey Venture Partners LLC

Relationship likelihood: Strong

Vice Chancellor of Innovation & Partnerships at University of California - San Francisco

Relationship likelihood: Strong

Paths to Walter H. Moos
Potential Connections via
Relationship Science
You
Walter H. Moos
Chief Executive Officer at ShangPharma Innovation, Inc.
Education
Ph.D. in Chemistry
Class of 1982

University of California Berkeley National rankings: In a National Research Council analysis of 212 doctoral programs at American universities, 48 Berkeley programs place among the top 10 nationwide. Faculty awards and honors: There are 8 Nobel Laureates, 32 MacArthur Fellows, and 4 Pulitzer Prize winners among the current faculty. History of UC Berkeley: Historical highlights, arranged by topic, following the campus's development — from UC's founding in 1868 to a turn-of-the-century building boom, a research explosion in the 1930s, the Free Speech Movement of the '60s, and Berkeley's key role today in science and technology revolutions. Timeline of discoveries and contributions by UC Berkeley scholars. Traditions of Cal: Who was the Angel of Death? What's with the "Big C" up there in the hills — and why is it sometimes green? Who wears Oski's jolly bear head and size 54 yellow sweater? Tours and webcams: Check out what's happening on Sproul Plaza, the campus's true heart. See stunning live views of the Bay Area from the Lawrence Hall of Science's perch in the Berkeley hills. Chancellor and administration: Information on Chancellor Robert Birgeneau, Executive Vice Chancellor and Provost George W. Breslauer, and how the university is organized. Organizational charts are included. UC System overview and links: On the campuses, laboratories, and medical centers that comprise UC's public educational system, as well as UC's K-12 partnerships, economic impact, and agriculture and environmental resources.

A.B.

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
Adjunct Professor
Current

The University of California, San Francisco (UCSF), is a center of health sciences research, patient care, and education; located in San Francisco, California. UCSF is widely regarded as one of the world's leading universities in health sciences. Though one of the 10 campuses of the University of California, it is unique for being the only University of California campus dedicated solely to graduate education, and in health and biomedical sciences. Some of UCSF's treatment centers include kidney transplants and liver transplantation, radiology, neurosurgery, neurology, oncology, ophthalmology, gene therapy, women's health, fetal surgery, pediatrics, and internal medicine.

Chief Executive Officer, Shangpharma Innovation
2017 - Current

Shangpharma Corp. provides pharmaceutical and biotechnology research outsourcing services. It offers various integrated services across the drug discovery and development process to international and chinese pharmaceutical and biotechnology companies, and academic and research institutions. The company was founded by Michael Xin Hui and Wenjuan Xiao in 2002 and is headquartered in Shanghai, China.

Chief Executive Officer
2017 - Current

ShangPharma Innovation invests in companies located in United States. The firm targets companies operating in the fields of health technology. They provide financing for seed and early stage capital requirement

Boards & Committees
Member, Board of Advisors
Current

Red Abbey Venture Partners invests across the life sciences spectrum, which includes biotechnology, specialty pharmaceutical, medical device, diagnostics and research tools companies. Their investments are diversified by geography, by stage of development, by sector and by therapeutic indication. The firm targets investments in North America and Europe. Red Abbey Venture Partners invests in both early- and late-stage companies and in PIPE transactions.

Director
Prior - 2008

Oncologic, Inc. develops patented technology for cancer treatment. The company was founded in January, 2000 by George Mayers, Sam Rose, Henry Rapoport & David S. Rose and is headquartered in Berkeley, CA

Member, Board of Directors
2004 - 2008

MIGENIX, Inc. develops pharmaceutical drugs. It focuses on advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I/II) and the treatment of acne (Phase II). MIGENIX was founded in 1993 and is headquartered in Vancouver, Canada.

Board Member
Prior

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Walter H. Moos. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Walter H. Moos's profile does not indicate a business or promotional relationship of any kind between RelSci and Walter H. Moos.